Posted On: 08/12/2015 6:36:50 AM
Post# of 98
Rodman & Renshaw 17th Annual Global Investment Conference
September 9–September 10, 2015
http://ir.actiniumpharma.com/ir-calendar
Not sure how many are keeping up to date on this one but I suggest up dating your DD.
5 Aug
announced today that it has issued a letter to shareholders providing an update on the progress it has made to advance its two drug candidates, Iomab-B and Actimab-A, towards commercialization. With a substantially stronger balance sheet following financing activity that yielded cash in excess of $25 million at June 30, 2015, the Company is well positioned to propel forward its research activities and transition its key programs with Iomab-B and Actimab-A through value creating milestones.
September 9–September 10, 2015
http://ir.actiniumpharma.com/ir-calendar
Not sure how many are keeping up to date on this one but I suggest up dating your DD.
5 Aug
announced today that it has issued a letter to shareholders providing an update on the progress it has made to advance its two drug candidates, Iomab-B and Actimab-A, towards commercialization. With a substantially stronger balance sheet following financing activity that yielded cash in excess of $25 million at June 30, 2015, the Company is well positioned to propel forward its research activities and transition its key programs with Iomab-B and Actimab-A through value creating milestones.
(0)
(0)Scroll down for more posts ▼
